Pharmaceutical Supply of Lidocaine Hydrochloride and Epinephrine Injection

The contract entails the supply and delivery of FDA-compliant Lidocaine Hydrochloride and Epinephrine Injection, USP, packaged in sealed containers that meet all federal standards for labeling, hazardous materials handling, and secure packaging. The product must adhere strictly to U.S. Pharmacopeia standards and regulatory requirements to ensure safety, potency, and compliance with federal guidelines for pharmaceutical distribution. Delivery is to be made to a military postal address in FPO with ZIP code 09588-2304, indicating service to Department of Defense facilities, likely for use in medical emergencies or field operations. This is a subcontract under the Medical Supply Chain Pharm FSA, issued by the Department of Defense, with a NAICS code of 325412 for pharmaceutical preparation manufacturing. The solicitation was posted on August 5, 2026, and responses are due by August 11, 2026. The contract requires full compliance with all federal regulations governing the transport and handling of hazardous pharmaceuticals, including proper documentation, packaging integrity, and adherence to U.S. Postal Service and Department of Transportation guidelines for shipping controlled substances. Bidders must demonstrate proven capability in supplying medical-grade injectables to federal entities under stringent quality and logistical standards.